Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6
Authors
Keywords
-
Journal
Cell Death Discovery
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-13
DOI
10.1038/s41420-023-01306-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The IL-6/STAT3/CTH axis deciphers the transformation between the sensitive and resistant phenotypes of breast cancer cells
- (2021) Zhaoyi Tan et al. DRUG METABOLISM AND DISPOSITION
- CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
- (2020) Haiyang Zhang et al. Molecular Cancer
- Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer
- (2020) Sunny Z Wu et al. EMBO JOURNAL
- Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells
- (2020) Emarndeena H. Cheteh et al. Cell Death Discovery
- Fibroblast-derived IL-33 facilitates breast cancer metastasis by modifying the immune microenvironment and driving type-2 immunity
- (2020) Ophir Shani et al. CANCER RESEARCH
- Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
- (2019) Eva A. Ebbing et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
- (2019) Jana Plava et al. Molecular Cancer
- Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
- (2019) In-Hye Ham et al. Molecular Cancer
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression
- (2019) Irina Primac et al. JOURNAL OF CLINICAL INVESTIGATION
- STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis
- (2019) Christina Heichler et al. GUT
- Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression
- (2018) Dhruv Kumar et al. CANCER RESEARCH
- IL-6 mediates cross-talk between activated fibroblasts and tumor cells in the tumor microenvironment
- (2018) Tatiana A Karakasheva et al. CANCER RESEARCH
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
- (2018) Yu Shi et al. Science Translational Medicine
- IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression
- (2018) Hoe Suk Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
- (2018) Mustafa Yassin Taher et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment
- (2018) J. M. Houthuijzen et al. CANCER AND METASTASIS REVIEWS
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma
- (2016) Yuichiro Matsuoka et al. BRITISH JOURNAL OF CANCER
- IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
- (2016) Yasushi Shintani et al. Journal of Thoracic Oncology
- Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go
- (2016) Rachel Buchsbaum et al. Cancers
- Cancer-associated fibroblasts: A multifaceted driver of breast cancer progression
- (2015) Haojun Luo et al. CANCER LETTERS
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
- (2015) A. Deisseroth et al. CLINICAL CANCER RESEARCH
- Therapeutic uses of anti-interleukin-6 receptor antibody
- (2014) S. Kang et al. INTERNATIONAL IMMUNOLOGY
- Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
- (2014) Frits van Rhee et al. LANCET ONCOLOGY
- Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer
- (2014) E Brighenti et al. ONCOGENE
- The two faces of IL-6 in the tumor microenvironment
- (2014) Daniel T. Fisher et al. SEMINARS IN IMMUNOLOGY
- STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer
- (2013) Yujuan Chen et al. Journal of Breast Cancer
- Therapeutic Targeting of the Interleukin-6 Receptor
- (2011) Toshio Tanaka et al. Annual Review of Pharmacology and Toxicology
- Prognostic significance of nuclear pSTAT3 in oral cancer
- (2010) Muzafar A. Macha et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Tocilizumab for Rheumatoid Arthritis: A Cochrane Systematic Review
- (2010) J. A. SINGH et al. JOURNAL OF RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now